Salix Pharmaceuticals Ltd. volatility and risk adjusted return

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) closed at $24.25 and shares are up 18% at $28.65 on 200893 shares as of 8:26 AM EST. The company reported that the FDA Advisory Committee recommended approval Of XIFAXAN? (rifaximin) tablets ...

? Below is a list of the companies that made news in the healthcare sector on Tuesday , February 23, 2010. Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) soared after hours today after the company reported that the Gastrointestinal Drugs ...

SLXP, ADSK, CIMT, GE, STEC, AAPL, VRGY, BCSI, C, SKS Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) $28.79 +18.72% FDA panel backs Salix antibiotic for liver disorder, shares rise (NASDAQ:SLXP), ($SLXP) Autodesk Inc. (NASDAQ: ADSK) $27.86 ...

Salix Beats but Outlook Disappoints (Zacks.com)

The current Zacks Consensus Estimate for the fourth quarter of 2009 is a loss of 14 cents. For the full year, the Zacks Consensus Estimate stands at a loss of 89 cents.

Good News for Salix (Zacks.com)